Open Label Phase I Clinical Trial of Crotoxin in Patients With Advanced Cancer Using an Intravenous Route of Administration
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Crotoxin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Celtic Biotech
- 31 Jan 2018 Planned End Date changed from 1 Jul 2018 to 1 Feb 2019.
- 31 Jan 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2018.
- 18 Jul 2017 Planned number of patients changed from 24 to 18.